United States · How much has Noninvasive Medical Technologies raised?
Noninvasive Medical Technologies has raised $6.3M across 1 round since 2009.
United States · Venture startup
Who invested in Noninvasive Medical Technologies
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Noninvasive Medical Technologies and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$6.3Mraised across 1 round since 2009, from 1 source
- Latest round
- Venture, $6.3MSept 2009
- Investors
- 0
The rounds
- Sept 2009Venture$6.3M
No investor was named in the report.
From a historical funding recordSEC filing: $6.3M sold, first sale Feb 2008
Funding filed with regulators
Noninvasive Medical Technologies filed one raise, $6.3M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Feb 2008$6.3MSEC Form D
Founders and team
From the SEC filings it signed: 5 on the team.
- Adam HodsonExecutive Officeri
- Ann McCaughanExecutive Officeri
- Katherine DeMarrExecutive Officer, Directori
- Ronald McCaughanExecutive Officer, Director, Promoteri
- Ted SpoltoreExecutive Officeri
On the board, as filediDennis McGrathMark McAlpine
Quick answers about Noninvasive Medical Technologies
When did Noninvasive Medical Technologies last raise?
Noninvasive Medical Technologies's most recent round was a Venture of $6.3M in Sept 2009.
What was Noninvasive Medical Technologies's biggest round?
Its most recent round, $6.3M in Sept 2009, is also its largest on record.
What stage is Noninvasive Medical Technologies at?
Noninvasive Medical Technologies's latest named round is a Venture, in Sept 2009.
Where is Noninvasive Medical Technologies based?
Noninvasive Medical Technologies is based in the United States.
Companies like Noninvasive Medical Technologies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.